Walgreens, AllianceRx Walgreens Pharmacy Study of Non-Infused Biologics in Rheumatoid Arthritis Treatment Underscores Importance of Medication Adherence
ORLANDO, Fla., Sept. 20, 2023 /PRNewswire/ -- A recent study evaluating the use of non-infused biologics in patients diagnosed with rheumatoid arthritis (RA) demonstrated that patients who are adherent to their non-infused RA biologic medication are more likely to have lower medical costs, odds of hospitalization and length of stay (LOS). AllianceRx Walgreens Pharmacy, a leading specialty and home delivery pharmacy, and Walgreens, one of the largest drug store chains in the U.S., conducted the retrospective cohort study.
- AllianceRx Walgreens Pharmacy , a leading specialty and home delivery pharmacy, and Walgreens , one of the largest drug store chains in the U.S., conducted the retrospective cohort study .
- The Pharmacy Quality Alliance (PQA) promotes a useful reporting metric of proportion of days covered (PDC) for non-infused biologic medications to treat RA.
- Renee Baiano, PharmD, CSP , clinical program manager for AllianceRx Walgreens Pharmacy and an author of the study, says the research findings underscore the importance of patients remaining adherent to their therapy.
- "Identifying barriers to adherence and educating patients on the importance of taking their medication can increase the patient's chance at disease improvement," says Dr. Baiano.